Targeting Hypoxia: Revival of Old Remedies

Tumour hypoxia is significantly correlated with patient survival and treatment outcomes. At the molecular level, hypoxia is a major driving factor for tumour progression and aggressiveness. Despite the accumulative scientific and clinical efforts to target hypoxia, there is still a need to find spec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nuria Vilaplana-Lopera, Maxym Besh, Eui Jung Moon
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2f1a5fafb1e94ff4b5dcacc6df687a95
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2f1a5fafb1e94ff4b5dcacc6df687a95
record_format dspace
spelling oai:doaj.org-article:2f1a5fafb1e94ff4b5dcacc6df687a952021-11-25T16:52:43ZTargeting Hypoxia: Revival of Old Remedies10.3390/biom111116042218-273Xhttps://doaj.org/article/2f1a5fafb1e94ff4b5dcacc6df687a952021-10-01T00:00:00Zhttps://www.mdpi.com/2218-273X/11/11/1604https://doaj.org/toc/2218-273XTumour hypoxia is significantly correlated with patient survival and treatment outcomes. At the molecular level, hypoxia is a major driving factor for tumour progression and aggressiveness. Despite the accumulative scientific and clinical efforts to target hypoxia, there is still a need to find specific treatments for tumour hypoxia. In this review, we discuss a variety of approaches to alter the low oxygen tumour microenvironment or hypoxia pathways including carbogen breathing, hyperthermia, hypoxia-activated prodrugs, tumour metabolism and hypoxia-inducible factor (HIF) inhibitors. The recent advances in technology and biological understanding reveal the importance of revisiting old therapeutic regimens and repurposing their uses clinically.Nuria Vilaplana-LoperaMaxym BeshEui Jung MoonMDPI AGarticlehypoxiacancertirapazaminehyperthermiacarbogen breathingtumour metabolismMicrobiologyQR1-502ENBiomolecules, Vol 11, Iss 1604, p 1604 (2021)
institution DOAJ
collection DOAJ
language EN
topic hypoxia
cancer
tirapazamine
hyperthermia
carbogen breathing
tumour metabolism
Microbiology
QR1-502
spellingShingle hypoxia
cancer
tirapazamine
hyperthermia
carbogen breathing
tumour metabolism
Microbiology
QR1-502
Nuria Vilaplana-Lopera
Maxym Besh
Eui Jung Moon
Targeting Hypoxia: Revival of Old Remedies
description Tumour hypoxia is significantly correlated with patient survival and treatment outcomes. At the molecular level, hypoxia is a major driving factor for tumour progression and aggressiveness. Despite the accumulative scientific and clinical efforts to target hypoxia, there is still a need to find specific treatments for tumour hypoxia. In this review, we discuss a variety of approaches to alter the low oxygen tumour microenvironment or hypoxia pathways including carbogen breathing, hyperthermia, hypoxia-activated prodrugs, tumour metabolism and hypoxia-inducible factor (HIF) inhibitors. The recent advances in technology and biological understanding reveal the importance of revisiting old therapeutic regimens and repurposing their uses clinically.
format article
author Nuria Vilaplana-Lopera
Maxym Besh
Eui Jung Moon
author_facet Nuria Vilaplana-Lopera
Maxym Besh
Eui Jung Moon
author_sort Nuria Vilaplana-Lopera
title Targeting Hypoxia: Revival of Old Remedies
title_short Targeting Hypoxia: Revival of Old Remedies
title_full Targeting Hypoxia: Revival of Old Remedies
title_fullStr Targeting Hypoxia: Revival of Old Remedies
title_full_unstemmed Targeting Hypoxia: Revival of Old Remedies
title_sort targeting hypoxia: revival of old remedies
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2f1a5fafb1e94ff4b5dcacc6df687a95
work_keys_str_mv AT nuriavilaplanalopera targetinghypoxiarevivalofoldremedies
AT maxymbesh targetinghypoxiarevivalofoldremedies
AT euijungmoon targetinghypoxiarevivalofoldremedies
_version_ 1718412883802456064